{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T08:53:17Z","timestamp":1776329597659,"version":"3.50.1"},"reference-count":40,"publisher":"Baskent University","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Clin Transplant"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.6002\/ect.2021.0013","type":"journal-article","created":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T08:42:17Z","timestamp":1618994537000},"page":"771-778","source":"Crossref","is-referenced-by-count":2,"title":["Donation After Circulatory Death Yields Survival Rates Similar to Donation After Brain Death Liver Transplant, Which Effectively Expands the Donor Pool"],"prefix":"10.6002","volume":"19","author":[{"given":"Navdeep","family":"Singh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katelynn","family":"Helfrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khalid","family":"Mumtaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth","family":"Washburn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"April","family":"Logan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvester","family":"Black","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Austin","family":"Schenk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashley","family":"Limkemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Musab","family":"Alebrahim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashraf","family":"El-Hinnawi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4021","reference":[{"key":"ref0","unstructured":"1. Organ Procurement and Transplantation Network. Overall waitlist by organ. Accessed March 25, 2020. https:\/\/opt.transplant.hrsa.gov\/data\/view-data-reports\/national-data\/#"},{"key":"ref1","unstructured":"2. Starzl TE, Marchioro TL, Vonkaulla KN, Hermann G, Brittain RS, Waddell WR. Homotransplantation of the liver in humans. Surg Gynecol Obstet. 1963;117:659-676."},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"3. Abt PL, Fisher CA, Singhal AK. Donation after cardiac death in the US: history and use. J Am Coll Surg. 2006;203(2):208-225. doi:10.1016\/j.jamcollsurg.2006.03.014","DOI":"10.1016\/j.jamcollsurg.2006.03.014"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"4. Taner CB, Bulatao IG, Willingham DL, et al. Events in procurement as risk factors for ischemic cholangiopathy in liver transplantation using donation after cardiac death donors. Liver Transpl. 2012;18(1):100-111. doi:10.1002\/lt.22404","DOI":"10.1002\/lt.22404"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"5. Selck FW, Grossman EB, Ratner LE, Renz JF. Utilization, outcomes, and retransplantation of liver allografts from donation after cardiac death: implications for further expansion of the deceased-donor pool. Ann Surg. 2008;248(4):599-607. doi:10.1097\/SLA.0b013e31818a080e","DOI":"10.1097\/SLA.0b013e31818a080e"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"6. Mateo R, Cho Y, Singh G, et al. Risk factors for graft survival after liver transplantation from donation after cardiac death donors: an analysis of OPTN\/UNOS data. Am J Transplant. 2006;6(4):791-796. doi:10.1111\/j.1600-6143.2006.01243.x","DOI":"10.1111\/j.1600-6143.2006.01243.x"},{"key":"ref6","unstructured":"7. Eren EA, Latchana N, Beal E, Hayes D, Jr., Whitson B, Black SM. Donations after circulatory death in liver transplant. Exp Clin Transplant. 2016;14(5):463-470."},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"8. Jay CL, Skaro AI, Ladner DP, et al. Comparative effectiveness of donation after cardiac death versus donation after brain death liver transplantation: recognizing who can benefit. Liver Transpl. 2012;18(6):630-640. doi:10.1002\/lt.23418","DOI":"10.1002\/lt.23418"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"9. Taylor R, Allen E, Richards JA, et al.; Liver Advisory Group to NHS Blood and Transplant. Survival advantage for patients accepting the offer of a circulatory death liver transplant. J Hepatol. 2019;70(5):855-865. doi:10.1016\/j.jhep.2018.12.033","DOI":"10.1016\/j.jhep.2018.12.033"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"10. Kollmann D, Sapisochin G, Goldaracena N, et al. Expanding the donor pool: donation after circulatory death and living liver donation do not compromise the results of liver transplantation. Liver Transpl. 2018;24(6):779-789. doi:10.1002\/lt.25068","DOI":"10.1002\/lt.25068"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"11. Scalea JR, Redfield RR, Foley DP. Liver transplant outcomes using ideal donation after circulatory death livers are superior to using older donation after brain death donor livers. Liver Transpl. 2016;22(9):1197-1204. doi:10.1002\/lt.24494","DOI":"10.1002\/lt.24494"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"12. Kwong A, Kim WR, Lake JR, et al. OPTN\/SRTR 2018 Annual Data Report: Liver. Am J Transplant. 2020;20 Suppl s1:193-299. doi:10.1111\/ajt.15674","DOI":"10.1111\/ajt.15674"},{"key":"ref12","unstructured":"13. Institute of Medicine (US) Committee on Non-Heart-Beating Transplantation II: The Scientific and Ethical Basis for Practice and Protocols. Non-Heart-Beating Organ Transplantation: Practice and Protocols. National Academies Press; 2000."},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"14. Hand DJ. Testing Statistical Hypotheses of Equivalence and Noninferiority, Second Edition by Stefan Wellek. Int Stat Rev. 2012;80(1):188-189. doi:10.1111\/j.1751-5823.2012.00179_12.x","DOI":"10.1111\/j.1751-5823.2012.00179_12.x"},{"issue":"6","key":"ref14","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1002\/bimj.4710380608","article-title":"A new approach to equivalence assessment in standard comparative bioavailability trials by means of the Mann\u2010Whitney statistic","volume":"38","author":"Wellek","year":"1996","unstructured":"15. Wellek S. A new approach to equivalence assessment in standard comparative bioavailability trials by means of the Mann\u2010Whitney statistic. Biometrical J. 1996;38(6):695-710.","journal-title":"Biometrical J"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"16. Bohorquez H, Seal JB, Cohen AJ, et al. Safety and outcomes in 100 consecutive donation after circulatory death liver transplants using a protocol that includes thrombolytic therapy. Am J Transplant. 2017;17(8):2155-2164. doi:10.1111\/ajt.14261","DOI":"10.1111\/ajt.14261"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"17. van der Hilst CS, Ijtsma AJ, Bottema JT, et al. The price of donation after cardiac death in liver transplantation: a prospective cost-effectiveness study. Transpl Int. 2013;26(4):411-418. doi:10.1111\/tri.12059","DOI":"10.1111\/tri.12059"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"18. Jay CL, Lyuksemburg V, Kang R, et al. The increased costs of donation after cardiac death liver transplantation: caveat emptor. Ann Surg. 2010;251(4):743-748. doi:10.1097\/SLA.0b013e3181d3d3da","DOI":"10.1097\/SLA.0b013e3181d3d3da"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"19. Ramirez P, Ferreras D, Febrero B, et al. Outcomes of liver transplantation using older donors after circulatory death and the super-rapid technique: 14 cases. Transplant Proc. 2018;50(2):601-604. doi:10.1016\/j.transproceed.2017.11.037","DOI":"10.1016\/j.transproceed.2017.11.037"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"20. Schlegel A, Scalera I, Perera M, et al. Impact of donor age in donation after circulatory death liver transplantation: is the cutoff \"60\" still of relevance? Liver Transpl. 2018;24(3):352-362. doi:10.1002\/lt.24865","DOI":"10.1002\/lt.24865"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"21. Mathur AK, Heimbach J, Steffick DE, Sonnenday CJ, Goodrich NP, Merion RM. Donation after cardiac death liver transplantation: predictors of outcome. Am J Transplant. 2010;10(11):2512-2519. doi:10.1111\/j.1600-6143.2010.03293.x","DOI":"10.1111\/j.1600-6143.2010.03293.x"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"22. Cursio R, Gugenheim J. Ischemia-reperfusion injury and ischemic-type biliary lesions following liver transplantation. J Transplant. 2012;2012:164329. doi:10.1155\/2012\/164329","DOI":"10.1155\/2012\/164329"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"23. Baccarani U, Adani GL, Isola M, et al. Steatosis of the graft is a risk factor for posttransplantation biliary complications. Transplant Proc. 2009;41(4):1313-1315. doi:10.1016\/j.transproceed.2009.03.084","DOI":"10.1016\/j.transproceed.2009.03.084"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"24. Schlegel A, Kalisvaart M, Scalera I, et al. The UK DCD Risk Score: A new proposal to define futility in donation-after-circulatory-death liver transplantation. J Hepatol. 2018;68(3):456-464. doi:0.1016\/j.jhep.2017.10.034","DOI":"10.1016\/j.jhep.2017.10.034"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"25. Pitarch Martinez M, Sanchez Perez B, Leon Diaz FJ, et al. Donation after cardiac death in liver transplantation: an additional source of organs with similar results to donation after brain death. Transplant Proc. 2019;51(1):4-8. doi:10.1016\/j.transproceed.2018.02.208","DOI":"10.1016\/j.transproceed.2018.02.208"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"26. Tang JX, Na N, Li JJ, Fan L, Weng RH, Jiang N. Outcomes of controlled donation after cardiac death compared with donation after brain death in liver transplantation: a systematic review and meta-analysis. Transplant Proc. 2018;50(1):33-41. doi:10.1016\/j.transproceed.2017.11.034","DOI":"10.1016\/j.transproceed.2017.11.034"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"27. O'Neill S, Roebuck A, Khoo E, Wigmore SJ, Harrison EM. A meta-analysis and meta-regression of outcomes including biliary complications in donation after cardiac death liver transplantation. Transpl Int. 2014;27(11):1159-1174. doi:10.1111\/tri.12403","DOI":"10.1111\/tri.12403"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"28. Jay CL, Lyuksemburg V, Ladner DP, et al. Ischemic cholangiopathy after controlled donation after cardiac death liver transplantation: a meta-analysis. Ann Surg. 2011;253(2):259-264. doi:10.1097\/SLA.0b013e318204e658","DOI":"10.1097\/SLA.0b013e318204e658"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"29. Jones JM, Bhutiani N, Wei D, Goldstein L, Jones CM, Cannon RM. A literature-based cost analysis of tissue plasminogen activator for prevention of biliary stricture in donation after circulatory death liver transplantation. Am J Surg. 2018;216(5):959-962. doi:10.1016\/j.amjsurg.2018.04.004","DOI":"10.1016\/j.amjsurg.2018.04.004"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"30. Doyle MB, Collins K, Vachharajani N, et al. Outcomes using grafts from donors after cardiac death. J Am Coll Surg. 2015;221(1):142-152. doi:10.1016\/j.jamcollsurg.2015.03.053","DOI":"10.1016\/j.jamcollsurg.2015.03.053"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"31. Yamamoto S, Wilczek HE, Duraj FF, Groth CG, Ericzon BG. Liver transplantation with grafts from controlled donors after cardiac death: a 20-year follow-up at a single center. Am J Transplant. 2010;10(3):602-611. doi:10.1111\/j.1600-6143.2009.02965.x","DOI":"10.1111\/j.1600-6143.2009.02965.x"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"32. de Vera ME, Lopez-Solis R, Dvorchik I, et al. Liver transplantation using donation after cardiac death donors: long-term follow-up from a single center. Am J Transplant. 2009;9(4):773-781. doi:10.1111\/j.1600-6143.2009.02560.x","DOI":"10.1111\/j.1600-6143.2009.02560.x"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"33. Levitsky J, Goldberg D, Smith AR, et al. Acute rejection increases risk of graft failure and death in recent liver transplant recipients. Clin Gastroenterol Hepatol. 2017;15(4):584-593 e582. doi:10.1016\/j.cgh.2016.07.035","DOI":"10.1016\/j.cgh.2016.07.035"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"34. Kwo PY, Badshah MB. New hepatitis C virus therapies: drug classes and metabolism, drug interactions relevant in the transplant settings, drug options in decompensated cirrhosis, and drug options in end-stage renal disease. Curr Opin Organ Transplant. 2015;20(3):235-241. doi:10.1097\/MOT.0000000000000198","DOI":"10.1097\/MOT.0000000000000198"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"35. Sanchez-Fueyo A, Restrepo JC, Quinto L, et al. Impact of the recurrence of hepatitis C virus infection after liver transplantation on the long-term viability of the graft. Transplantation. 2002;73(1):56-63. doi:10.1097\/00007890-200201150-00010","DOI":"10.1097\/00007890-200201150-00010"},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"36. Forman LM, Lewis JD, Berlin JA, Feldman HI, Lucey MR. The association between hepatitis C infection and survival after orthotopic liver transplantation. Gastroenterology. 2002;122(4):889-896. doi:10.1053\/gast.2002.32418","DOI":"10.1053\/gast.2002.32418"},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"37. Patel MS, Mohebali J, Shah JA, Markmann JF, Vagefi PA. Readmission following liver transplantation: an unwanted occurrence but an opportunity to act. HPB (Oxford). 2016;18(11):936-942. doi:10.1016\/j.hpb.2016.08.003","DOI":"10.1016\/j.hpb.2016.08.003"},{"key":"ref37","doi-asserted-by":"publisher","unstructured":"38. Wilson GC, Hoehn RS, Ertel AE, et al. Variation by center and economic burden of readmissions after liver transplantation. Liver Transpl. 2015;21(7):953-960. doi:10.1002\/lt.24112","DOI":"10.1002\/lt.24112"},{"key":"ref38","doi-asserted-by":"publisher","unstructured":"39. Russo MW, Levi DM, Pierce R, et al. A prospective study of a protocol that reduces readmission after liver transplantation. Liver Transpl. 2016;22(6):765-772. doi:10.1002\/lt.24424","DOI":"10.1002\/lt.24424"},{"key":"ref39","doi-asserted-by":"publisher","unstructured":"40. Singhal A, Wima K, Hoehn RS, et al. Hospital resource use with donation after cardiac death allografts in liver transplantation: a matched controlled analysis from 2007 to 2011. J Am Coll Surg. 2015;220(5):951-958. doi:10.1016\/j.jamcollsurg.2015.01.052","DOI":"10.1016\/j.jamcollsurg.2015.01.052"}],"container-title":["Experimental and Clinical Transplantation"],"original-title":[],"deposited":{"date-parts":[[2021,8,20]],"date-time":"2021-08-20T02:44:06Z","timestamp":1629427446000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.ectrx.org\/detail\/current\/2021\/19\/8\/0\/771\/0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":40,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"URL":"https:\/\/doi.org\/10.6002\/ect.2021.0013","relation":{},"ISSN":["1304-0855","2146-8427"],"issn-type":[{"value":"1304-0855","type":"print"},{"value":"2146-8427","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8]]}}}